Publications by authors named "Bhavani Anagani"

Article Synopsis
  • Three series of CLK1 inhibitors were designed, synthesized, and tested against CLKs and DYRK1A kinases for their effectiveness in killing cancer cells.
  • The research focused on modifying part of the chemical structure, leading to the discovery of a new derivative that is highly effective with low inhibition concentrations for both CLK1 and DYRK1A.
  • A comprehensive analysis showed that this new compound is highly selective for CLK inhibition, indicating its potential for developing targeted cancer treatments.
View Article and Find Full Text PDF

During our work on exploration of molecules with some piperidine-triazole scaffolds, we realized that our compounds display chemical similarity with some σ, as well as dopaminergic receptor ligands. Here we show that this series of molecules has indeed strong affinity both for σ1 and dopamine D4 receptors. Moreover, they appear selective towards σ2, dopamine paralogues D1, D2, D3 and D5 receptors and hERG channel.

View Article and Find Full Text PDF

A small library of new piperidine-triazole hybrids with 3-aryl isoxazole side chains has been designed and synthesized. Their cytotoxicity against a panel of seven cancer cell lines has been established. For the most promising compound, an IC value of 3.

View Article and Find Full Text PDF

A simple synthetic route affording 27%-85% yields of benzo[6,7][1,5]diazocino[2,1-a]isoindol-12(14H)-one ring systems from readily available 3-(2-oxo-2-phenylethyl) isobenzofuran-1(3H)-ones and 2-(aminomethyl)aniline starting materials in toluene and catalysed by p-toluene-sulfonic acid is developed. The ¹H- and (13)C-NMR spectra of the final products were assigned using a variety of one and two-dimensional NMR experiments. The distinction between the two potential isomers of the final products was made on the basis of heteronuclear multiple bond connectivity (HMBC) NMR spectra.

View Article and Find Full Text PDF